{"database": "lobbying", "table": "lobbying_activities", "rows": [[1558804, "5c9f9130-5eba-4fc9-ab7e-37870fad0cad", "Q2", "TARPLIN, DOWNS & YOUNG, LLC", 304736, "ASTRAZENECA", 2014, "second_quarter", "PHA", "**see addendum pagePL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation \nH.R. 2186 - Valid Compounding Act\nH.R. 3204  The Drug Quality and Security Act, implementation\nH.R. 2725, S. 1413 - Safety Over Sequester Act, user fee sequester relief\n\n\n***, no specific bill(s), Import Safety, Prescription Drug User Fee Act renewal, drug development policy, drug shortages, supply chain integrity, patent settlements, user fee sequester relief, 21st Century Cures", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2014-07-18T10:47:45.217000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1558804"], "units": {}, "query_ms": 16.15628704894334, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}